Medicare Enrolled

Dr. Arun Agarwal, M.D.

Pulmonary Disease · Brewster, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
111 CLOCKTOWER COMMONS, Brewster, NY 10509
8452795187
In practice since 2005 (20 years)
NPI: 1073590493 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Agarwal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Agarwal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Agarwal

Dr. Arun Agarwal is a pulmonary disease specialist in Brewster, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Agarwal performed 2,829 Medicare services across 1,757 unique beneficiaries.

Between the years covered by Open Payments, Dr. Agarwal received a total of $161,039 from 56 pharmaceutical and/or device companies across 615 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Agarwal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 13% volume in NY $161,039 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,829
Medicare services
Top 13% in NY for pulmonary disease
1,757
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~141 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,046 $101 $368
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
519 $71 $259
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
172 $8 $12
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
140 $68 $198
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
130 $7 $245
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
129 $9 $200
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
127 $10 $176
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
78 $86 $333
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
78 $141 $504
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
74 $107 $376
Initial nursing facility care, moderate complexity
Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes.
65 $119 $359
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
61 $103 $381
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
46 $67 $192
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
45 $156 $512
New patient office visit, complex (60-74 min) 37 $182 $626
Sleep study in sleep lab (age 6+)
An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older.
32 $90 $1,257
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
28 $148 $553
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
22 $70 $260
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$161,039
Total received (2018-2024)
Avg $23,006/year across 7 years
Top 3% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
615
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$145,722 (90.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,855 (4.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,463 (4.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$35,058
2023
$34,810
2022
$38,468
2021
$14,261
2020
$2,472
2019
$18,404
2018
$17,566

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$34,031
Grifols USA, LLC
$990
Alnylam Pharmaceuticals Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$101,420
Grifols USA, LLC
$31,526
Genentech USA, Inc.
$11,431
Boehringer Ingelheim Pharmaceuticals, Inc.
$6,909
Amgen Inc.
$3,192
GlaxoSmithKline, LLC.
$1,712
Grifols Shared Services North America, Inc.
$660
Janssen Pharmaceuticals, Inc
$475
GENZYME CORPORATION
$373
Insmed, Inc.
$294
HARMONY BIOSCIENCES LLC
$255
Novartis Pharmaceuticals Corporation
$217
Regeneron Healthcare Solutions, Inc.
$213
Harmony Biosciences LLC
$176
Shire North American Group Inc
$176
Genentech, Inc.
$125
Radius Health, Inc.
$120
United Therapeutics Corporation
$100
Avanir Pharmaceuticals, Inc.
$99
Amarin Pharma Inc.
$94
Veran Medical Technologies, Inc.
$93
PFIZER INC.
$89
JAZZ PHARMACEUTICALS INC.
$79
Kowa Pharmaceuticals America, Inc.
$69
Pulmonx Corporation
$67
Teva Pharmaceuticals USA, Inc.
$66
Mallinckrodt Hospital Products Inc.
$65
Corcept Therapeutics
$62
Jazz Pharmaceuticals Inc.
$62
Abbott Laboratories
$55
Takeda Pharmaceuticals U.S.A., Inc.
$55
Lundbeck LLC
$52
Philips Electronics North America Corporation
$52
ARBOR PHARMACEUTICALS, INC.
$48
Aurinia Pharma U.S., Inc.
$48
Electromed, Inc.
$45
Merck Sharp & Dohme Corporation
$38
Novo Nordisk Inc
$36
Bayer HealthCare Pharmaceuticals Inc.
$35
Impulse Dynamics (USA) Inc.
$35
Mannkind Corporation
$33
Arbor Pharmaceuticals, Inc.
$28
Sunovion Pharmaceuticals Inc.
$26
Mylan Specialty L.P.
$22
Alnylam Pharmaceuticals Inc.
$20
IBSA Pharma Inc.
$20
MannKind Corporation
$20
Insulet Corporation
$20
Astellas Pharma US Inc
$19
Akcea Therapeutics, Inc.
$18
ADVANCED RESPIRATORY, INC
$18
TherapeuticsMD, Inc.
$16
AbbVie, Inc.
$16
Vanda Pharmaceuticals Inc.
$15
AKEBIA THERAPEUTICS INC
$15
OPKO Pharmaceuticals, LLC
$14
Top 3 companies account for 89.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AFREZZA · ANORO · ANORO ELLIPTA · AirDuo Digihaler · Arikayce · Auryxia · BEVESPI AEROSPHERE · BOOSTRIX · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · CHANTIX · CINQAIR · CardioMEMS HF System · DUPIXENT · ELIQUIS · Edarbi · Esbriet · FARXIGA · FASENRA · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GLASSIA · HETLIOZ · IMVEXXY · INVOKANA · JANUVIA · JARDIANCE · KEVZARA · Kerendia · Korlym · LOKELMA · LONHALA MAGNAIR · LUPKYNIS · Livalo · MYRBETRIQ · NATPARA · NORTHERA · NUCALA · NUEDEXTA · OFEV · OPTIMIZER · Omnipod · Ozempic · PREVNAR - 13 · Prolastin-C · Prolastin-C Liquid · Prolia · Pulmonx Endobronchial Valve EBV · RAYALDEE · SMARTVEST · SPIRIVA · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Synthroid · TEGSEDI · TEZSPIRE · TRELEGY ELLIPTA · The Vest System Model 105 Home Care · Tirosint · Tresiba · Tymlos · Utibron · Vascepa · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xembify · Xolair · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for pulmonary disease in NY.

Looking for a pulmonary disease specialist in Brewster?
Compare pulmonary diseases in the Brewster area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
59
Per 100K population
60.2
County median income
$127,405
Nearest hospital
PUTNAM HOSPITAL CENTER
6.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Agarwal is a clinical cardiology specialist, with above-average Medicare volume (top 13% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Agarwal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Agarwal performed 1,046 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Agarwal receive payments from pharmaceutical companies?
Yes. Dr. Agarwal received a total of $161,039 from 56 companies across 615 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Agarwal's costs compare to other pulmonary diseases in Brewster?
Dr. Agarwal's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Agarwal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →